|
|
|
|
|
Session 140
Poster Abstracts HIV and Reproductive Health Friday, 1:30 - 3:30 pm Hall B |
Background: The French law has allowed assisted
reproductive techniques for HIV-infected patients since May 2001. We report
here our 3 years’ experience concerning infected women.
Methods: We referred 67 HIV+ women to our center for assisted reproductive techniques; 46 files are
already complete. For 10 couples, infection concerned both partners. The median
age of the patients was 36 (25 to 44), their median follicle-stimulating
hormone basal level was 6,7 IU/L (0.1 to 13); 30 women
were treated with ART, and 16 did not need any treatment. Their infection was
well controlled with a median CD4 count of 471/mm3 [196 to 2449].
Plasmatic viral load was indetectable for 60.8% of the patients and was 2860
copies/mL [60 to 294,000] for the others. Assisted
reproductive techniques were proposed to avoid male contamination for all the couples and for
the treatment of an associated infertility for 28 couples: male infertility 5, female infertility 19,
mixed infertility 3, preimplantation genetic diagnosis
1.
Results: For 34 couples, 73 cycles of ovarian
stimulation have already been performed leading to 8 arrests of stimulation and
65 assisted reproductive procedures: intrauterine insemination 7, in vitro fertilization 8,
intracytoplasmic sperm injection 42, and frozen-thawed embryo transfer 8. For in vitro fertilization and intracytoplasmic sperm injection, the median number of
retrieved oocytes was 8.0 (0 to 17). At the first attempt, an elective single
embryo transfer was performed for women aged < 35. Assisted reproductive
techniques resulted in 12 single pregnancies: none after intrauterine insemination or in vitro fertilization, 10 after intracytoplasmic sperm injection and 2 after frozen embryo
transfer. Intracytoplasmic sperm injection, on
account of a 23.8% pregnancy rate per retrieval, soon became our standard
procedure: 7 babies are born, 2
miscarriages occurred, and 3 pregnancies are ongoing. A pregnancy was obtained
for 35.3% of the couples and 20.6% of the couples are already parents. All
the women were treated with ART at the end of their pregnancy, even if not
treated before. Babies were born via caesarean section. They are healthy and
postnatal viral load screening is negative. They are not fed at the breast.
Conclusions: As previously demonstrated for HIV seropositive
men, our results show that assisted reproductive techniques are feasible and
safe for HIV seropositive women. Assisted reproductive techniques are efficient
in avoiding contamination of the partner. Assisted reproductive techniques,
especially intracytoplasmic sperm injection, also treat
possible associated infertility with acceptable results in a population whose
ovarian reserve may be impaired.
Keywords: ART; HIV; women
![]() |